Related Experiment Video
Updated: Sep 9, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
Prevalence and Associated Factors for HPV in People Living with HIV: Are INSTIs Protective Against HPV-16? The GAIA
Omar Hernández-López1, Brenda Clara González-Contreras2, Ana Luz Cano-Díaz1
1Infectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Abstract:
Human papillomavirus (HPV) significantly contributes to anogenital cancers, with elevated risks among people living with HIV (PWH), particularly men who have sex with men (MSM). This study assessed anal HPV prevalence and associated risk factors in PWH in Mexico, focusing on the role of antiretroviral therapy (ART). Methods: A cross-sectional study at an HIV clinic in Mexico City (October 2023-December 2024) enrolled 214 MSM with HIV. The participants completed a validated risk factor questionnaire and provided anal samples for real-time PCR testing of 28 HPV genotypes. Logistic regression analyzed associations between HPV infection, ART regimens, and clinical/behavioral factors. Results: HPV prevalence was 89.3%, with HPV-16 (20.1%) being the most common high-risk genotype. Integrase inhibitor (INSTI) use was inversely associated with HPV-16 infection (OR: 0.42; 95% CI: 0.21-0.83; p = 0.011), while protease inhibitor use increased HPV-16 (OR: 2.16; 95% CI: 1.09-4.29; p = 0.025) and HPV-6 risks. Higher CD4+ counts (≥500 cells/mm3) and undetectable HIV viral load (<40 copies/mL) were protective against multiple HPV genotypes. Lower education and smoking increased HPV risk. Conclusions: This first Mexican study in the ART and HPV vaccination era highlights high anal HPV prevalence in PWH and suggests that INSTI-based regimens may reduce HPV-16 risk, informing ART selection for HPV prevention.
Insights
High anal human papillomavirus (HPV) prevalence was found in people living with HIV (PWH) in Mexico. Integrase inhibitor therapy may reduce HPV-16 risk in these individuals.
Area of Science:
- Oncology
- Virology
- Infectious Diseases
Background:
- Human papillomavirus (HPV) is a major cause of anogenital cancers.
- People living with HIV (PWH), especially men who have sex with men (MSM), have elevated risks.
- Understanding HPV prevalence and risk factors in PWH in Mexico is crucial.
Purpose of the Study:
- To assess anal HPV prevalence and associated risk factors in PWH in Mexico.
- To investigate the role of antiretroviral therapy (ART) regimens in HPV infection.
- To identify factors influencing HPV infection in this population.
Main Methods:
- Cross-sectional study at an HIV clinic in Mexico City (October 2023-December 2024).
- 214 MSM with HIV completed questionnaires and provided anal samples for HPV genotyping via real-time PCR.
- Logistic regression analyzed associations between HPV, ART, and clinical/behavioral factors.
Main Results:
- HPV prevalence was 89.3%, with HPV-16 being the most common high-risk genotype (20.1%).
- Integrase inhibitor (INSTI) use was linked to lower HPV-16 risk (OR: 0.42), while protease inhibitor use increased HPV-16 and HPV-6 risks.
- Higher CD4+ counts and undetectable HIV viral load were protective; lower education and smoking increased risk.
Conclusions:
- This study reveals high anal HPV prevalence in Mexican PWH.
- INSTI-based ART regimens may offer a protective effect against HPV-16 infection.
- Findings inform ART selection for HPV prevention strategies in PWH.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Mechanisms of Retrovirus-induced Cancers
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Cancer Prevention
Some...